Pharmaceutical firm Canbex, a spin-out of University College London, has received a grant for £1.25m ($1.77m) from the TSB Biocatalyst Fund. The injection of cash from the fund, a joint venture between the UK’s Medical Research Council and Technology Strategy Board to support British life sciences, will be used to support the ongoing development of…
Canbex keeps the grants coming
Sep 6, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Dec 14, 2023
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024